Neuraminidase Inhibitors

DBCAT002200Therapeutic categoryJ05AH

A DrugBank category of 5 drugs. 3 of them are approved.

ATC classification: J — ANTIINFECTIVES FOR SYSTEMIC USE
J05 — ANTIVIRALS FOR SYSTEMIC USE
J05A — DIRECT ACTING ANTIVIRALS
J05AH — Neuraminidase inhibitors
Also known as: Antiviral neuraminidase inhibitors · Neuraminidase inhibitors (NAIs)
Drugs: Laninamivir
Oseltamivir
Oseltamivir acid
Peramivir
Zanamivir

What you can answer from here — as of May 20, 2021

5DrugsEach linked to its full drug card

Listed above

7Drug targetsEvery drug–target pair in the class, with bond type

357Marketed productsAcross the regions we cover, with dosage forms and routes

5Routes of administrationHow the drugs in this class are given

Which targets do Neuraminidase Inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.